Peter D. Kies
2022
In 2022, Peter D. Kies earned a total compensation of $1.6M as Chief Financial Officer at Inovio Pharmaceuticals, a 30% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $155,940 |
|---|---|
| Option Awards | $466,386 |
| Salary | $518,552 |
| Stock Awards | $463,358 |
| Other | $14,232 |
| Total | $1,618,468 |
Kies received $518.6K in salary, accounting for 32% of the total pay in 2022.
Kies also received $155.9K in non-equity incentive plan, $466.4K in option awards, $463.4K in stock awards and $14.2K in other compensation.
Rankings
In 2022, Peter D. Kies' compensation ranked 2,102nd out of 5,756 executives tracked by ExecPay. In other words, Kies earned more than 63.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,102 out of 5,756 | 64th |
Division Manufacturing | 1,128 out of 3,133 | 64th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 134 out of 485 | 72nd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 87 out of 347 | 75th |
Industry Surgical and Medical Instruments and Apparatus | 73 out of 253 | 71st |
Source: SEC filing on March 28, 2023.
Kies' colleagues
We found three more compensation records of executives who worked with Peter D. Kies at Inovio Pharmaceuticals in 2022.
News
Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
April 11, 2024
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021
Inovio Pharmaceuticals CEO J Kim's 2018 pay falls 30% to $3.1M
March 25, 2019